FDAClass IIMarch 18, 2020

Carbidopa and Levodopa Tablets recall

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

Why was Carbidopa and Levodopa Tablets recalled?

Product Mix-Up: A foreign tablet was found in bottle.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: FG11514 Exp. 05/2021

Product
Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01
Recalling firm
Mayne Pharma Inc
Quantity
8274 100-count bottles
Distribution
Distributed Nationwide in the USA
Recall date
March 18, 2020
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls